Acute and long-term results of interventional treatment of paravalvular leaks after prosthetic valve replacement with plug devices: results from a prospective multicentre registry.

IF 3.8 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Hanna Konrad, Nicolas Werner, Taoufik Ouarrak, Joachim Schofer, Edith Lubos, Volker Geist, Holger Eggebrecht, Christian Butter, Thomas Schmitz, Ulrich Schäfer, Burghard Schumacher, Steffen Schneider, Uwe Zeymer, Ralf Zahn
{"title":"Acute and long-term results of interventional treatment of paravalvular leaks after prosthetic valve replacement with plug devices: results from a prospective multicentre registry.","authors":"Hanna Konrad, Nicolas Werner, Taoufik Ouarrak, Joachim Schofer, Edith Lubos, Volker Geist, Holger Eggebrecht, Christian Butter, Thomas Schmitz, Ulrich Schäfer, Burghard Schumacher, Steffen Schneider, Uwe Zeymer, Ralf Zahn","doi":"10.1007/s00392-025-02681-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Interventional closure of symptomatic paravalvular leaks (PVL) after valve replacement has developed to an attractive treatment option for patients at high operative risk. However, prospective and long-term data are sparse.</p><p><strong>Methods: </strong>We analysed data from a multicentre prospective registry on interventional PVL closure.</p><p><strong>Results: </strong>41 patients with symptomatic PVL were included in the plug registry at nine German hospitals from 2014 until 2020. In total 50 interventions with 67 plug implantations were recorded, 46.3% of procedures were performed for aortic and 53.7% for mitral PVLs. In 82% of patients PVL closure was performed once, in 16% twice and 2% underwent three procedures. Indication for PVL closure was symptomatic heart failure with NYHA class ≥ II (63.4%), haemolysis (4.9%), or NYHA class ≥ II and haemolysis (31.7%). PVL closure was completely successful in 76%, partially successful in 10% and failed in 14%. Acute improvement of one NYHA class was achieved in 56.4% and of two NYHA classes in 15.4%. Postprocedural no residual severe aortic PVL was described and residual severe mitral PVL was seen in 4.8%. Postinterventional complications occurred in 21.9%. In-hospital mortality rate was 4.9%. A follow-up was performed after 30 days, 12 months, 3 and 5 years. Calculated mortality rates were 10.1% at 1-year-, 18.5% at 3-year- and 32.5% at 5-year-follow-up. The estimated rates for mortality and/or reintervention (surgical or interventional) were 25.6% at 1-year, 36.8% at 3-year and 45.1% at 5-year follow-up.</p><p><strong>Conclusions: </strong>The multicentre German Plug-Registry describes a high procedural success rate with clinical improvement in most patients and acceptable long-term outcomes after percutaneous PVL closure.</p><p><strong>Trial registration number: </strong>NCT03179969.</p>","PeriodicalId":10474,"journal":{"name":"Clinical Research in Cardiology","volume":" ","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Research in Cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00392-025-02681-w","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Interventional closure of symptomatic paravalvular leaks (PVL) after valve replacement has developed to an attractive treatment option for patients at high operative risk. However, prospective and long-term data are sparse.

Methods: We analysed data from a multicentre prospective registry on interventional PVL closure.

Results: 41 patients with symptomatic PVL were included in the plug registry at nine German hospitals from 2014 until 2020. In total 50 interventions with 67 plug implantations were recorded, 46.3% of procedures were performed for aortic and 53.7% for mitral PVLs. In 82% of patients PVL closure was performed once, in 16% twice and 2% underwent three procedures. Indication for PVL closure was symptomatic heart failure with NYHA class ≥ II (63.4%), haemolysis (4.9%), or NYHA class ≥ II and haemolysis (31.7%). PVL closure was completely successful in 76%, partially successful in 10% and failed in 14%. Acute improvement of one NYHA class was achieved in 56.4% and of two NYHA classes in 15.4%. Postprocedural no residual severe aortic PVL was described and residual severe mitral PVL was seen in 4.8%. Postinterventional complications occurred in 21.9%. In-hospital mortality rate was 4.9%. A follow-up was performed after 30 days, 12 months, 3 and 5 years. Calculated mortality rates were 10.1% at 1-year-, 18.5% at 3-year- and 32.5% at 5-year-follow-up. The estimated rates for mortality and/or reintervention (surgical or interventional) were 25.6% at 1-year, 36.8% at 3-year and 45.1% at 5-year follow-up.

Conclusions: The multicentre German Plug-Registry describes a high procedural success rate with clinical improvement in most patients and acceptable long-term outcomes after percutaneous PVL closure.

Trial registration number: NCT03179969.

人工瓣膜置换术后瓣旁泄漏介入治疗的急性和长期结果:来自前瞻性多中心注册的结果
背景:介入治疗有症状的瓣旁泄漏(PVL)在瓣膜置换术后已经发展成为一种有吸引力的治疗选择,患者的手术风险高。然而,前瞻性和长期的数据很少。方法:我们分析了来自多中心前瞻性登记的介入PVL闭合数据。结果:从2014年到2020年,41例有症状的PVL患者被纳入德国9家医院的堵塞登记。总共记录了50例干预,67例塞植入,46.3%的手术用于主动脉,53.7%的手术用于二尖瓣心室搏动。82%的患者进行了一次PVL闭合,16%的患者进行了两次,2%的患者进行了三次闭合。PVL闭合的适应症为NYHA≥II级(63.4%)、溶血(4.9%)或NYHA≥II级、溶血(31.7%)的症状性心力衰竭。PVL闭合完全成功的占76%,部分成功的占10%,失败的占14%。一个NYHA级别的急性改善率为56.4%,两个NYHA级别的急性改善率为15.4%。术后无主动脉瓣严重PVL残留,4.8%为二尖瓣严重PVL残留。介入后并发症发生率为21.9%。住院死亡率为4.9%。随访时间分别为30天、12个月、3年和5年。计算死亡率为1年10.1%,3年18.5%,5年32.5%。估计死亡率和/或再干预率(手术或介入性)1年时为25.6%,3年时为36.8%,5年时为45.1%。结论:多中心德国Plug-Registry描述了高手术成功率,大多数患者的临床改善和经皮PVL闭合后可接受的长期结果。试验注册号:NCT03179969。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Research in Cardiology
Clinical Research in Cardiology 医学-心血管系统
CiteScore
11.40
自引率
4.00%
发文量
140
审稿时长
4-8 weeks
期刊介绍: Clinical Research in Cardiology is an international journal for clinical cardiovascular research. It provides a forum for original and review articles as well as critical perspective articles. Articles are only accepted if they meet stringent scientific standards and have undergone peer review. The journal regularly receives articles from the field of clinical cardiology, angiology, as well as heart and vascular surgery. As the official journal of the German Cardiac Society, it gives a current and competent survey on the diagnosis and therapy of heart and vascular diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信